Please wait

Exhibit 107

Calculation of Filing Fee Table

Form S-8

(Form Type)

Xeris Biopharma Holdings, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

Security Type			Security Class Title			Fee Calculation Rule			Amount Registered (1)			Proposed Maximum Offering Price Per Share			Maximum Aggregate Offering Price			Fee Rate			Amount of Registration Fee
Equity			2018 Stock Option and Incentive Plan Common Stock, $0.0001 par value per share			Other (2)			5,977,176 (3)			$3.69 (2)			$22,055,779.44			$0.00015310			$3,376.74
Total Offering Amounts															$22,055,779.44						—
Total Fees Previously Paid																					—
Total Fee Offsets																					—
Net Fee Due																					$3,376.74

(1)    In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions effected without the receipt of consideration which results in an increase in the number of the outstanding shares of the registrant’s common stock, $0.0001 par value per share (“Common Stock”).

(2)    The price of $3.69 per share, which is the average of the high and low sale prices of the Common Stock of the registrant as quoted on the Nasdaq Global Market on March 4, 2025, is set forth solely for purposes of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act.

(3)    Consists of 5,977,176 additional shares issuable under the 2018 Stock Option and Incentive Plan (the “2018 Plan”), which represents the automatic annual increase to the number of shares available for issuance under the 2018 Plan, effective as of January 1, 2025.